Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV608 in Social Anxiety Disorder
NCT00294346Phase 2Completed
- Sponsor
- Avera Pharmaceuticals
- Start
- Feb 2006
- Primary completion
- Dec 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AV608 in Social Anxiety Disorder (SAD), sponsored by Avera Pharmaceuticals. Started Feb 2006; status: completed.
02
Drugs
AV608
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00294346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294346.